newsfilter
← Latest News
Business Wire·

Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue

Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported preliminary unaudited revenue for